Paper30837992
BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity.
Abate G and 3 others. Front Immunol, 2019. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity. Papers, record 30837992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30837992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BCG Vaccine | Major topic |
| Cross Reactions | Major topic |
| Mycobacterium abscessus | Major topic |
| Mycobacterium avium | Major topic |
| Tuberculosis | Major topic |
| Adolescent | |
| Adult | |
| Animals | |
| Cells, Cultured | |
| Female | |
| Humans | |
| Interferon-gamma | |
| Leukocytes, Mononuclear | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Middle Aged | |
| T-Lymphocytes | |
| Vaccination | |
| Young Adult |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI048391 | NIAID NIH HHS | United States | R01AI048391 | PubMed |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07094711 | Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST) | Results |
Source ClinicalTrials.gov
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10588596 | Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection. | Am J Respir Crit Care Med | 1999 | https://conductscience.org/library/papers/10588596 | PubMed |
| 2 | 10992491 | Interaction of Mycobacterium avium with human monocyte-derived dendritic cells. | Infect Immun | 2000 | https://conductscience.org/library/papers/10992491 | PubMed |
| 3 | 11133380 | Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. | J Infect Dis | 2001 | https://conductscience.org/library/papers/11133380 | PubMed |
| 4 | 11358435 | Infection of mice with Mycobacterium avium primes CD8+ lymphocytes for apoptosis upon exposure to macrophages. | Clin Immunol | 2001 | https://conductscience.org/library/papers/11358435 | PubMed |
| 5 | 11454066 | Interleukin-12 primes CD4+ T cells for interferon-gamma production and protective immunity during Mycobacterium avium infection. | Immunology | 2001 | https://conductscience.org/library/papers/11454066 | PubMed |
| 6 | 11721060 | Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. | Science | 2001 | https://conductscience.org/library/papers/11721060 | PubMed |
| 7 | 11781383 | Mycobacterium avium infection of macrophages results in progressive suppression of interleukin-12 production in vitro and in vivo. | J Leukoc Biol | 2002 | https://conductscience.org/library/papers/11781383 | PubMed |
| 8 | 12368910 | HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. | Nat Immunol | 2002 | https://conductscience.org/library/papers/12368910 | PubMed |
| 9 | 12433668 | Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. | Am J Respir Crit Care Med | 2003 | https://conductscience.org/library/papers/12433668 | PubMed |
| 10 | 12654790 | Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. | Infect Immun | 2003 | https://conductscience.org/library/papers/12654790 | PubMed |
| 11 | 12924521 | Pathological findings of bronchiectases caused by Mycobacterium avium intracellulare complex. | Respir Med | 2003 | https://conductscience.org/library/papers/12924521 | PubMed |
| 12 | 14636245 | Apoptosis of CD4+ and CD8+ T cells during experimental infection with Mycobacterium avium is controlled by Fas/FasL and Bcl-2-sensitive pathways, respectively. | Immunol Cell Biol | 2003 | https://conductscience.org/library/papers/14636245 | PubMed |
| 13 | 15336223 | Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. | Lancet Infect Dis | 2004 | https://conductscience.org/library/papers/15336223 | PubMed |
| 14 | 15557609 | Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection. | Infect Immun | 2004 | https://conductscience.org/library/papers/15557609 | PubMed |
| 15 | 15845464 | CD4+ T cells but Not CD8+ or gammadelta+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route. | Infect Immun | 2005 | https://conductscience.org/library/papers/15845464 | PubMed |
| 16 | 16000428 | Clinical and prognostic importance of serotyping Mycobacterium avium-Mycobacterium intracellulare complex isolates in human immunodeficiency virus-negative patients. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/16000428 | PubMed |
| 17 | 16170753 | Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions. | J Infect Dis | 2005 | https://conductscience.org/library/papers/16170753 | PubMed |
| 18 | 16943387 | Mycobacterium avium-induced SOCS contributes to resistance to IFN-gamma-mediated mycobactericidal activity in human macrophages. | J Leukoc Biol | 2006 | https://conductscience.org/library/papers/16943387 | PubMed |
| 19 | 17277290 | An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. | Am J Respir Crit Care Med | 2007 | https://conductscience.org/library/papers/17277290 | PubMed |
| 20 | 17875636 | Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. | Infect Immun | 2007 | https://conductscience.org/library/papers/17875636 | PubMed |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42368276 | Infantile pulmonary abscess due to Mycobacterium abscessus subsp. massiliense identified by integrated mNGS and targeted NGS: a rare case report. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42368276 | PubMed |
| 41624833 | Flavin and deazaflavin biosynthesis in mycobacteria: relevance to physiology, implications for drug discovery, MR-1 antigenicity, and vaccine development. | Front Immunol | 2025 | https://conductscience.org/library/papers/41624833 | PubMed |
| 41294882 | The Crosstalk Between Mycobacterium abscessus and Immune Cells: Exploring Novel Interaction Modalities. | Cells | 2025 | https://conductscience.org/library/papers/41294882 | PubMed |
| 40573950 | Immunity Against Mycobacterium avium Induced by DAR-901 and BCG. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40573950 | PubMed |
| 40415550 | Pathogenicity and virulence of Mycobacterium abscessus. | Virulence | 2025 | https://conductscience.org/library/papers/40415550 | PubMed |
| 40175984 | Paediatric cervicofacial lymphadenitis caused by non-tuberculous mycobacteria: nation-wide overview in the period 2000-2020. | BMC Pediatr | 2025 | https://conductscience.org/library/papers/40175984 | PubMed |
| 39452774 | Assays for Assessing Mycobacterium avium Immunity and Evaluating the Effects of Therapeutics. | Pathogens | 2024 | https://conductscience.org/library/papers/39452774 | PubMed |
| 39416778 | ELISA-R: an R-based method for robust ELISA data analysis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39416778 | PubMed |
| 38764556 | Effects of non-tuberculous mycobacteria on BCG vaccine efficacy: A narrative review. | J Clin Tuberc Other Mycobact Dis | 2024 | https://conductscience.org/library/papers/38764556 | PubMed |
| 38380095 | Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38380095 | PubMed |
| 37638056 | Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines. | Front Immunol | 2023 | https://conductscience.org/library/papers/37638056 | PubMed |
| 37631881 | Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis? | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37631881 | PubMed |
| 37515037 | Improving Protection to Prevent Bacterial Infections: Preliminary Applications of Reverse Vaccinology against the Main Cystic Fibrosis Pathogens. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37515037 | PubMed |
| 36677340 | Diagnosis and Management of Pulmonary NTM with a Focus on Mycobacterium avium Complex and Mycobacterium abscessus: Challenges and Prospects. | Microorganisms | 2022 | https://conductscience.org/library/papers/36677340 | PubMed |
| 36586154 | Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen. | Tuberculosis (Edinb) | 2023 | https://conductscience.org/library/papers/36586154 | PubMed |
| 36566170 | Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery. | Respir Res | 2022 | https://conductscience.org/library/papers/36566170 | PubMed |
| 36523585 | Drug resistance patterns and dynamics of tuberculosis in Zhejiang Province, China: Results from five periodic longitudinal surveys. | Front Public Health | 2022 | https://conductscience.org/library/papers/36523585 | PubMed |
| 36289979 | Alternatives to Antibiotics against Mycobacterium abscessus. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36289979 | PubMed |
| 35889173 | Mycobacterium abscessus: It's Complex. | Microorganisms | 2022 | https://conductscience.org/library/papers/35889173 | PubMed |
| 35790208 | The Association Between Bacille Calmette-Guérin Vaccination and Nontuberculous Mycobacterial Pulmonary Disease. | J Korean Med Sci | 2022 | https://conductscience.org/library/papers/35790208 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30837992
GET https://conductscience.org/api/papers/v1/30837992/references?page=2